BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27721021)

  • 1. Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.
    Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D
    Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.
    Bu Y; Li X; He Y; Huang C; Shen Y; Cao Y; Huang D; Cai C; Wang Y; Wang Z; Liao DF; Cao D
    Int J Cancer; 2016 Mar; 138(5):1186-98. PubMed ID: 26375985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
    Shin D; Kim EH; Lee J; Roh JL
    Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
    Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
    Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.
    Mobaraki RN; Karimi M; Alikarami F; Farhadi E; Amini A; Bashash D; Paridar M; Kokhaei P; Rezvani MR; Kazemi A; Safa M
    Anticancer Drugs; 2018 Oct; 29(9):847-853. PubMed ID: 30157040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.
    Nihira K; Ando Y; Yamaguchi T; Kagami Y; Miki Y; Yoshida K
    Cell Death Differ; 2010 Apr; 17(4):689-98. PubMed ID: 19911008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
    Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
    Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF
    World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B.
    Zheng J; Lee HL; Ham YW; Song HS; Song MJ; Hong JT
    Oncotarget; 2015 Dec; 6(42):44437-51. PubMed ID: 26561202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS/Epac1-mediated Rap1/NF-kappaB activation is required for the expression of BAFF in Raw264.7 murine macrophages.
    Moon EY; Lee JH; Lee JW; Song JH; Pyo S
    Cell Signal; 2011 Sep; 23(9):1479-88. PubMed ID: 21596132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
    Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of STAT3 Phosphorylation and RelA/p65 Acetylation Mediated by MicroRNA134 Plays a Pivotal Role in the Apoptotic Effect of Lambertianic Acid.
    Sim DY; Lee HJ; Jung JH; Im E; Hwang J; Kim DS; Kim SH
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
    Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
    Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells.
    Pan X; Jiang B; Liu J; Ding J; Li Y; Sun R; Peng L; Qin C; Fang S; Li G
    Oncotarget; 2017 Jul; 8(28):46249-46261. PubMed ID: 28545028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling.
    Yang X; Ding Y; Xiao M; Liu X; Ruan J; Xue P
    Chem Biol Interact; 2017 Dec; 278():22-31. PubMed ID: 28987325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB.
    Du J; Wang Y; Chen D; Ji G; Ma Q; Liao S; Zheng Y; Zhang J; Hou Y
    Cancer Lett; 2016 Dec; 383(2):145-153. PubMed ID: 27721019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response in the relapsing-remitting experimental autoimmune encephalomyelitis in mice: The role of the NF-κB signaling pathway.
    Lunin SM; Khrenov MO; Glushkova OV; Parfenyuk SB; Novoselova TV; Novoselova EG
    Cell Immunol; 2019 Feb; 336():20-27. PubMed ID: 30553438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.